Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Barbara Depreter

ORCID iD: 0000-0002-5019-1672

Show Sort by

Add to list
TARP as antigen in cancer immunotherapy

Jolien Vanhooren (UGent) , Charlotte Derpoorter (UGent) , Barbara Depreter, Larissa Deneweth (UGent) , Jan Philippé (UGent) , Barbara De Moerloose (UGent) and Tim Lammens (UGent)

(2021) CANCER IMMUNOLOGY IMMUNOTHERAPY.
Add to list
Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Barbara Depreter, Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , Anne Uyttebroeck, An Van Damme, Eva Terras (UGent) , Barbara Denys (UGent) , Laurence Dedeken, Marie-Francoise Dresse, Jutte Van der Werff Ten Bosch, et al.

(2021) PEDIATRIC RESEARCH. 89(7). p.1695-1705
Add to list
- Journal Article
- A2
- open access
Leukaemic stem cells in AML : where are we now? An update on recent findings and detection

Barbara Depreter, Barbara De Moerloose (UGent) , Jan Philippé (UGent) and Tim Lammens (UGent)

(2020) BELGIAN JOURNAL OF HEMATOLOGY. 11(6). p.246-252
Add to list
- PhD Thesis
Exploring the molecular and phenotypical heterogeneity between patients with pediatric acute myeloid leukemia

Barbara Depreter

(2020)
Add to list
- Journal Article
- A1
- open access
Clinical significance of TARP expression in pediatric acute myeloid leukemia

Barbara Depreter, Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , Anne Uyttebroeck, An Van Damme, Barbara Denys, Laurence Dedeken, Marie-Françoise Dresse, Jutte Van Der Werff Ten Bosch, Mattias Hofmans (UGent) , et al.

(2020) HEMASPHERE. 4(2).
Add to list
- Journal Article
- A1
- open access
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Barbara Depreter, Karin Weening (UGent) , Karl Vandepoele (UGent) , Magnus Essand, Barbara De Moerloose (UGent) , Maria Themeli, Jacqueline Cloos, Diana Hanekamp, Ine Moors (UGent) , Inge D'hont (UGent) , et al.

(2020) HAEMATOLOGICA. 105(5). p.1306-1316
Add to list
- Conference Paper
- C3
Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia : proof of concept study

Mattias Hofmans (UGent) , Barbara Depreter, Tim Lammens (UGent) , Helene Cave, Christian Flotho, Henrik Hasle, Valerie de Haas, Charlotte M. Niemeyer, Jan Stary, Pieter Van Vlierberghe (UGent) , et al.

(2019) BLOOD. 134(Supplement 1). p.1701-1701
Add to list
- Conference Paper
- C3
Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

Barbara Depreter, Mattias Hofmans (UGent) , Eva Terras (UGent) , Anne Uyttebroeck, An Van Damme, Alina Ferster, Jutte Van der Werff Ten Bosch, Marie-Françoise Dresse, Karl Vandepoele (UGent) , Barbara De Moerloose (UGent) , et al.

(2019) BLOOD. 134(S1). p.1457-1457
Add to list
- Conference Paper
- C3
- open access
Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

Barbara Depreter, Mattias Hofmans (UGent) , Eva Terras (UGent) , Anne Uyttebroeck, An Van Damme, Alina Ferster, Jutte van der Werff ten Bosch, Marie-Françoise Dresse, Karl Vandepoele (UGent) , Barbara De Moerloose (UGent) , et al.

(2019) American Society of Hematology, 61st Annual meeting, Abstracts.
Add to list
- Conference Paper
- C3
- open access
TARP as immunotherapeutic target in AML expressed in the LSC compartment

Barbara Depreter, Karin Weening (UGent) , Karl Vandepoele (UGent) , M Essand, Barbara De Moerloose (UGent) , M Themeli, J Cloos, D Hanekamp, Ine Moors (UGent) , Inge D'hont (UGent) , et al.

(2019) HEMASPHERE. 3(suppl. 1). p.54-54

1
2
3

Next →